Document is current
Any future updates will be listed below
-
Authors
Zhong, Haiping
Wei, Tuo https://orcid.org/0000-0002-2823-9721
Zhou, Xueyan
Yu, Na
Nakagawa, Yoshiyuki
Santamaria, Claudia
Gordon, Akiva https://orcid.org/0000-0002-6679-2974
Wang, Weiping https://orcid.org/0000-0001-7511-3497
Mu, Jingqing
Zhan, Changyou https://orcid.org/0000-0002-5215-2829
Wang, Hanzhang
Guo, Shuang-Zhuang https://orcid.org/0000-0002-9658-0120
Barhoumi, Aoune
Yuan, Xiaoyong
Kohane, Daniel S. https://orcid.org/0000-0001-5369-5932
Guo, Shutao https://orcid.org/0000-0002-0916-7451
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (51773098)
U.S. Department of Health & Human Services | National Institutes of Health (R35 GM131728)
- License Information
-
More Information
Article History
Received: 25 February 2025
Accepted: 16 April 2026
First Online: 29 April 2026
Competing interests
: D.K. and S.G. are inventors on patent related to drug-polyketal MPs technology (US11071714B2). The remaining authors declare no competing interests.
